MENU
+Compare
PRPO
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$10.87
Change
-$0.37 (-3.29%)
Capitalization
9.51M

PRPO Precipio Forecast, Technical & Fundamental Analysis

Precipio Inc is a healthcare solutions company focused on cancer diagnostics... Show more

Industry: #Biotechnology
PRPO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PRPO with price predictions
Jun 27, 2025

Aroon Indicator for PRPO shows an upward move is likely

PRPO's Aroon Indicator triggered a bullish signal on June 20, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 132 similar instances where the Aroon Indicator showed a similar pattern. In of the 132 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

The 10-day RSI Indicator for PRPO moved out of overbought territory on June 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 40 cases where PRPO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on June 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PRPO as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PRPO turned negative on June 13, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.751) is normal, around the industry mean (24.463). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.634) is also within normal values, averaging (43.062).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PRPO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRPO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
PRPO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PRPO is expected to report earnings to rise 566.67% to -160 cents per share on November 13

Precipio PRPO Stock Earnings Reports
Q3'23
Est.
$-1.60
Q4'24
Missed
by $0.98
Q2'23
Beat
by $0.20
Q1'23
Missed
by $2.47
Q4'22
Missed
by $1.97
The last earnings report on March 27 showed earnings per share of -23 cents, missing the estimate of 74 cents. With 13.24K shares outstanding, the current market capitalization sits at 9.51M.
A.I. Advisor
published General Information

General Information

a provider of medical diagnostics services

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4 Science Park
Phone
+1 203 787-7888
Employees
56
Web
https://www.precipiodx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMPS2.770.11
+4.14%
COMPASS Pathways Plc
ACTU5.950.13
+2.23%
Actuate Therapeutics Inc
GSUN2.38N/A
-0.04%
Golden Sun Health Technology Group Limited
CMS69.01-0.15
-0.22%
CMS Energy Corp
USAC24.40-0.08
-0.33%
USA Compression Partners LP

PRPO and Stocks

Correlation & Price change

A.I.dvisor tells us that PRPO and TLSI have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRPO and TLSI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRPO
1D Price
Change %
PRPO100%
-3.31%
TLSI - PRPO
23%
Poorly correlated
+4.93%
TNON - PRPO
20%
Poorly correlated
+3.26%
FLGT - PRPO
13%
Poorly correlated
+0.41%
NAOV - PRPO
12%
Poorly correlated
+34.62%
MYO - PRPO
11%
Poorly correlated
+1.80%
More